BioSpace News Archive

Policy

Legal Battle Over Between ‘Pharma Bro’ Martin Shkreli and Retrophin

Two weeks after filing a lawsuit against his former company from prison, Martin Shkreli has reached a settlement with Retrophin.

June 21, 2019
·
3 min read
·
Alex Keown
Policy

FDA Issues Guidance to Assess Benefit-Risk of Opioids Prior to Approval

The regulatory agency is establishing new standards for the approval of opioid medications.

June 21, 2019
·
2 min read
·
Alex Keown
Deals

Six Biotech Companies with IPOs This Week

This week marked initial public offering news from six biopharma companies. Here’s a look.

June 21, 2019
·
3 min read
·
Mark Terry
Policy

Trump Expected to Issue Executive Order in Attempt to Lower Health Care Costs

The order would compel healthcare providers, such as hospitals, to disclose information about negotiated and discounted costs of care.

June 21, 2019
·
3 min read
·
Alex Keown
Drug Development

Clinical Catch-Up for June 17-21

Plenty of biopharma companies released results from clinical trials last week. Here’s a look at the top stories.

June 21, 2019
·
4 min read
·
Mark Terry
Drug Development

Genentech & Exelixis’ Late-Stage Melanoma Combination Falls Short in Phase III Trial

The Phase III trial paired Exelixis and Genentech’s Cotellic with a checkpoint inhibitor in advanced melanoma.

June 21, 2019
·
2 min read
·
Alex Keown
Drug Development

Research May Lead to New Ways of Preventing Pancreatic Cancer

Although progress has been made in treating the disease, it’s still often fatal, and is made up of multiple diseases.

June 21, 2019
·
2 min read
·
Mark Terry
FDA

Allergan’s Botox Approved for Pediatric Limb Spasticity Amid Split-Up Rumors

Allergan announced that the U.S. Food and Drug Administration has approved its wrinkle treatment Botox for children with upper limb spasticity. The news comes just days after rumors that the company may break up.

June 21, 2019
·
2 min read
·
Mark Terry
Business

New Study Points Finger at How Surgeons Contributed to Opioid Epidemic

The data indicated that some surgeons prescribed more than 100 opioid pills for the week after a surgery. However, current guidelines from several academic medical centers called for zero to 10 pills for many of the procedures analyzed, with up to 30 for coronary bypass surgery.

June 21, 2019
·
3 min read
·
Mark Terry
FDA

FDA Action Alert: Regeneron, Sanofi, Celgene

July looks to be a quiet month for the U.S. Food and Drug Administration (FDA), and it sure looks like the agency is trying to get a lot of work done before the July 4 holiday. Here’s a look at the many approvals scheduled for this week.

June 21, 2019
·
4 min read
·
Mark Terry